ArticleCirculation. Heart failure2025
Impact of the Swedish Care Coordination Act on Heart Failure Readmissions and Length of Stay.
Article in Circulation. Heart failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with heart failure tend to experience higher rates of hospital readmissions compared with other ambulatory care-sensitive conditions. In Sweden, the nationwide Care Coordination Act (CCA) was introduced in January 2018 with the goal of improving care coordination, resulting in a reduction of readmissions and length of stay. There is insufficient knowledge regarding the effect of this reform on patients with heart failure.
methodsWe studied the association of implementing CCA on all-cause 30-day readmissions and length of stay for patients over 65 years of age with
resultsA total of 111 414 admissions were included. The average readmission rate for patients with heart failure was 26.8% before and 26.7% after the CCA. The average length of stay was 8.4 days before the CCA and 8.1 days after. Mortality within 30 days was 7.3% before the CCA and 7.5% after. There were no significant differences between the periods before and after. In an analysis assessing the overall linear time trend 2 of 21 regions showed a reduction in readmissions and 10 in length of stay.
conclusionsAfter introducing the CCA, no detectable impact was found on readmissions or mortality for patients with heart failure, which is in line with previous studies, such as those studying the US Hospital Readmission Reduction Program. Although no overall association with length of stay could be identified, it was reduced in several Swedish regions. The heterogeneity between regions could be used to understand the specific components needed to achieve the reduction of readmissions in future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.